PD-1 Inhibitor and Nab-paclitaxel and Bevacizumab in CUP

Clinical trial NCT04848597 · UNKNOWN

Trial details

NCT number: NCT04848597
Sponsor: Fudan University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Cancer of Unknown Primary

Start date: 2021-05-13
Primary completion: 2023-05-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.